Dynatrace Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Dynatrace Inc. Common Stock trades at $63.48 (market cap $17.66B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.3× Dynatrace Inc. Common Stock's market cap, and Dynatrace Inc. Common Stock is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dynatrace Inc. Common Stock for 1 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| DT | RVMD | |
|---|---|---|
Market Cap | $17.66B | $40.32B |
Volume | 8,779,681 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $61.12 | $221.15 |
52-Week Low | $32.36 | $47.50 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $16.71B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Dynatrace provides an observability, security, and automation platform for cloud and IT environments. Its platform integrates data such as logs, metrics, and traces to help organizations monitor digital systems.
Read more on DT →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →